Meeting
2022 ASCO Annual Meeting
Association of RB1 mutational status with overall genomic landscape in neuroendocrine prostate cancer (NEPC).
Authors
Petros Grivas
University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA
Petros Grivas , Gennady Bratslavsky , Joseph M Jacob , Oleksandr Kravtsov , Andrea Necchi , Philippe E. Spiess , David R Wise , Natalie Danziger , Vamsi Parimi , Ethan Sokol , Hanna Tukachinsky , Mia Alyce Levy , Jeffrey S. Ross
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer– Advanced/Castrate-Resistant
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5063)
DOI
10.1200/JCO.2022.40.16_suppl.5063
Abstract #
5063
Poster Bd #
246
Abstract Disclosures
Similar Posters
First Author: Petros Grivas
Poster
2023 ASCO Genitourinary Cancers Symposium
Single and multi-hit PIK3CA short variant (SV) genomic alterations (GA) in clinically advanced prostate cancer (CAPC): A genomic landscape study.
First Author: Carla Miguel
Poster
2020 Genitourinary Cancers Symposium
Comprehensive genomic profiling (CGP) in post-systemic treatment (Post) metastatic sites (MET) and pretreatment (Pre) primary tumors (PT) of metastatic prostate cancer (mPC).
First Author: Andrea Necchi
Poster
2019 ASCO Annual Meeting
Ductal (PDC), acinar (PAC) and neuroendocrine (PNC) carcinomas of the prostate: A comparative comprehensive genomic profiling (CGP) study.
First Author: Gennady Bratslavsky